Mirage News·3 min read·medium
New Brain Cancer Treatment Listed on PBS
✦AI Summary
Australia has listed the drug VORANIGO (vorasidenib) on the Pharmaceutical Benefits Scheme for patients with Grade 2 IDH-mutant glioma. This marks the first new treatment for this rare brain cancer in over two decades.
VORANIGO(r) (vorasidenib) is available on the Pharmaceutical Benefits Scheme (PBS) for eligible patients living with Grade 2 IDH-mutant gliomai
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in